Patents Assigned to Biomune, Inc.
  • Tumor and infectious disease therapeutic compositions
    Patent number: 8114972
    Abstract: A pharmaceutical composition comprising lectins is anti-tumorigenic and anti-viral, bacterial or protozoan. The composition, termed BiOmune is also useful for imaging, diagnosis and therapy of cancer.
    Type: Grant
    Filed: February 25, 2008
    Date of Patent: February 14, 2012
    Assignee: Biomune, Inc.
    Inventor: James Spencer Lipton